Literature DB >> 2012074

Heparin-induced thrombocytopenia and thrombosis: reversal with streptokinase. A case report and review of literature.

D P Mehta1, E L Yoder, J Appel, K L Bergsman.   

Abstract

Heparin-induced thrombocytopenia and thrombosis is associated with a significant incidence of morbidity and mortality. Prompt recognition of this complication and immediate withdrawal of heparin therapy are imperative. This report describes a case of heparin-induced thrombosis and thrombocytopenia with major vascular insufficiency of the extremities. This is the first reported instance of the use of intravenous streptokinase for the treatment of heparin-induced venous thrombosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2012074     DOI: 10.1002/ajh.2830360410

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  6 in total

Review 1.  Heparin-induced thrombocytopenia and thrombosis.

Authors:  G Arepally; D B Cines
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  The heparin-induced thrombocytopenia and thrombosis syndrome: treatment with intraarterial urokinase and systemic platelet aggregation inhibitors.

Authors:  K D Murphy; G McCrohan; D A DeMarta; N B Shirodkar; O J Kwon; P S Chopra
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Mar-Apr       Impact factor: 2.740

3.  Heparin-induced Thrombocytopenia.

Authors:  Marie Gerhard-Herman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-06

4.  Catastrophic heparin-induced thrombocytopenia/thrombosis syndrome related to the use of a Port-A-Cath in a breast cancer patient receiving chemotherapy.

Authors:  Ming-Shen Dai; An-Tie Hsieh; Tsu-Yi Chao
Journal:  Support Care Cancer       Date:  2004-04-28       Impact factor: 3.603

Review 5.  Benefit-risk assessment of treatments for heparin-induced thrombocytopenia.

Authors:  Harry Messmore; Walter Jeske; William Wehrmacher; Jeanine Walenga
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopenia.

Authors:  Ahmad Mirdamadi
Journal:  ARYA Atheroscler       Date:  2013-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.